UNMC's Green Labs Program to build on successful pilot - From left, Cole Holderjano, a graduate research assistant, and Vandana Singh, PhD, a postdoctoral research associate, served as navigators for the ... - https://t.co/1a6Mz5mSxH
If you care about access to affordable medical tests for all, please sign this petition. I just did!
Ask @DanaherCorp & @CepheidNews to put #PeopleOverProfits by reducing the price of ALL their lifesaving GeneXpert tests to $5 each – to save more lives!
https://t.co/FNpDEHhelT
. @DanaherCorp makes 8 billion dollars in annual profits. Much of that profit comes from price-gouging the world's poorest countries for life-saving tuberculosis tests. Danaher has done this in the dark for 13 long years.
Today, we shine the light. #PeopleOverProfits
@CepheidNews & @DanaherCorp – A GeneXpert test costs less than $5 to make, but you charge poor countries fighting TB 4 times that amount? People who need these tests the most are paying with their lives. Enough! It’s #TimeFor5!
Like many intentionally confusing corporate crisis response messages, this says a bunch of things that are true but don’t mean what you think, like for example:
“On April 5, during a World Health Organization meeting, the GDF shared its intent to launch a tender for generic versions of SIRTURO® 100mg in the third quarter of 2023”
This sounds like it says “everybody can have generic bedaquiline!!” But actually they *had to allow* the production of a generic because some countries had the power and systems in place to reject their attempt to extend their patent. The generic will not be available in countries where the patent extension wasn’t rejected, just like John said in his video.
Unless that’s not the case @JNJNews!!
If you’re telling us that you will allow the sale of generics anywhere in the developing world then we will happily send thank you baskets to your entire c-suite! Please let us know! Maybe we got it wrong and you only did the arduous work of extending the patent in a bunch of developing countries for funsies!
Still no word from @JNJGlobalHealth on whether they will keep pursuing secondary patents on bedaquiline, which they know would cost hundreds of thousands of lives. The pressure will continue until J&J announces they will abandon this deadly attempt to evergreen their patent.
For more information. Literally millions of people will unnecessarily die if J&J does not alter their course : https://t.co/jiB9drvqDd
@JNJNews @JNJGlobalHealth #ShameOnJNJ#bedaquiline#tuberculosis
For 20 years Johnson and Johnson has held the patent on bedaquiline, an incredibly useful drug in treating MDR Tuberculosis. Instead of letting the patent sunset, J&J is using legal loopholes to prevent generics from being delivered in some of the poorest countries in the world.
In the 1960s, Pittsburgh’s Freedom House Ambulance Service supplanted the police in a role in which they were not effective, reimagined the role of Black citizens in improving community health, and helped establish national standards for emergency medical care.
Blood products are vital for trauma patients and children with cancer alike. COVID19 has caused blood donations to greatly decline. Please consider donating blood this week. If you are sheltering in place, donating blood is a state-approved exception to the shelter order!
If you aren't offering your employees the flu shot you're leaving money on the table. Check out the data. Make better business decisions. https://t.co/S3jd0FW0cd
#fightflu#makemoney2
Not getting the flu-vaccine is the most "popular" form antivaxxing. Influenza the most popular infectious disease killer in the U.S. Learn more at https://t.co/oXF1ukTdUp
#fightflu#antivaxx#getflushot